NKGen Biotech Inc.

OTC: NKGN
Share price (7/16/25): $0.26
Market cap (7/16/25): $11.7 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

Late quarterly filing notification for Q1 2025

Late annual filing notification for FY 2024

ended 09/30/24 Q3

Late quarterly filing notification for Q3 2024

ended 06/30/24 Q2

Prospectuses and Registrations Filter

Removal from listing

Prospectus supplement

Prospectus supplement

Prospectus supplement

Initial registration of new securities – amended

Ownership Filter

CFIC-2015 NV Family Investments, LLC

Cherng Peggy, CFIC-2015 NV Family Investments, LLC, Cherng Andrew Jin-Chan

Meteora Capital, LLC

News Filter

NKGen Biotech and HekaBio Enter Strategic Partnership to Bring Novel NK Cell Therapy to Japan

Announces New Funding to Regain Compliance With Reporting Obligations and Listing Standards

Other Events, Financial Statements or Exhibits

Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements or Exhibits

Chairman & CEO Paul Y. Song, M.D., Personally Invests $2.65 Million Cash to Accelerate Phase 2 Clinical Trial and Fulfill Financial Reporting Obligations

Proxies Filter

Definitive proxy

Preliminary proxy

Definitive proxy

Preliminary revised proxy

Preliminary proxy

Other Filter

Scanned paper annual report submission

Notice of effectiveness

Correspondence with the SEC

Correspondence with the SEC

Letter from the SEC